These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9809208)

  • 21. The neurodevelopmental effects of serotonin: a behavioural perspective.
    Kepser LJ; Homberg JR
    Behav Brain Res; 2015 Jan; 277():3-13. PubMed ID: 24859172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The serotonin concept of depression in light of the mechanism of action of antidepressant drugs].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1989; 23(2):117-24. PubMed ID: 2682712
    [No Abstract]   [Full Text] [Related]  

  • 23. Models of antidepressant action.
    Berman RM; Charney DS
    J Clin Psychiatry; 1999; 60 Suppl 14():16-20; discussion 31-5. PubMed ID: 10408421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of depression: the current state and perspectives of the development of pharmacological studies].
    Ivanetz NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):108-16. PubMed ID: 25614913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does neurotropin-3 have a therapeutic implication in major depression?
    Pae CU; Marks DM; Han C; Patkar AA; Steffens D
    Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression.
    Lesch KP; Aulakh CS; Wolozin BL; Murphy DL
    Pharmacol Toxicol; 1992; 71 Suppl 1():49-60. PubMed ID: 1480560
    [No Abstract]   [Full Text] [Related]  

  • 27. Boosting serotonin in the brain: is it time to revamp the treatment of depression?
    Torrente MP; Gelenberg AJ; Vrana KE
    J Psychopharmacol; 2012 May; 26(5):629-35. PubMed ID: 22158544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurogenesis: a novel strategy for the treatment of depression].
    Zhang LM; Li YF; Gong ZH
    Sheng Li Ke Xue Jin Zhan; 2005 Apr; 36(2):109-12. PubMed ID: 16222968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is serotonin the main culprit in depression?
    Toren P; Weizman A
    Isr J Med Sci; 1994 Feb; 30(2):160-1. PubMed ID: 8150604
    [No Abstract]   [Full Text] [Related]  

  • 30. The cellular neurobiology of depression.
    Manji HK; Drevets WC; Charney DS
    Nat Med; 2001 May; 7(5):541-7. PubMed ID: 11329053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical aspects of susceptibility to depression.
    Nathan PJ
    JAMA; 2003 Sep; 290(10):1315-6; author reply 1316. PubMed ID: 12966120
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytokines as mediators of depression: what can we learn from animal studies?
    Dunn AJ; Swiergiel AH; de Beaurepaire R
    Neurosci Biobehav Rev; 2005; 29(4-5):891-909. PubMed ID: 15885777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current state and potential of pharmacogenetic studies in the treatment of depression].
    Ivanets NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):113-121. PubMed ID: 26171487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatments for depression.
    Kent S
    Geriatrics; 1982 Nov; 37(11):149-51. PubMed ID: 6982191
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antidepressant psychopharmacotherapy].
    Retamal P
    Rev Med Chil; 2001 Jul; 129(7):813-8. PubMed ID: 11552452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression, suicide and the metabolism of serotonin in the brain.
    Van Praag HM
    J Affect Disord; 1982 Dec; 4(4):275-90. PubMed ID: 6186712
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies.
    Caldecott-Hazard S; Schneider LS
    Synapse; 1992 Feb; 10(2):141-68. PubMed ID: 1585257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invivo antioxidant status: a putative target of antidepressant action.
    Zafir A; Ara A; Banu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):220-8. PubMed ID: 19059298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC
    J Clin Psychiatry; 2004; 65 Suppl 4():31-6. PubMed ID: 15046539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.